Global Veterinary Medicine Market Growth is Expected to driven by increased pet adoption
![]() |
Veterinary Medicine Market |
The
global veterinary medicine market has witnessed tremendous growth over the past
decade. Veterinary medicines are specialized pharmaceutical products intended
for administration to animals for therapeutic or preventive purposes. They
include drugs used for the treatment of various animal diseases and infections
as well as vaccines for prevention of various zoonotic and non-zoonotic
diseases. The growing demand for pets such as dogs and cats has spurred the
need for veterinary medicines to keep companion animals healthy. According to
the American Pet Products Association, U.S. pet industry spending reached $99
billion in 2020 alone, representing strong growth in demand over the years.
The
global veterinary medicine market is estimated to be valued at US$ 39.27
million in 2024 and is expected to exhibit a CAGR of 5.0% over the forecast
period 2024 to 2031, as highlighted in a new report published by Coherent
Market Insights.
Market key trends: One of the major trends fueling market growth is the rising
incidence of zoonotic and food-borne diseases which requires effective
prevention through vaccination of livestock animals reared for food. New
product launches and innovations are also boosting the market as manufacturers
are bringing novel medications and drug-delivery systems to make treatment more
efficient and convenient. For instance, in 2021, Boehringer Ingelheim launched
Credelio, a orally administered tick and flea chewable tablet for dogs, which
offers year-long parasite protection with just one monthly administration. Such
developments are expected to positively influence market revenues over the
forecast period.
Porter's Analysis
Threat of new entrants: Low to medium as new companies need to make huge
investments and significant economies of scale to compete in this market.
However, established players face threat from new players providing niche
products.
Bargaining power of buyers: Medium as buyers have multiple options and
substitute products to choose from. However, switching costs limit their power.
Bargaining power of suppliers: Medium as key raw materials like active
pharmaceutical ingredients have a limited number of suppliers globally.
Established supplier relationships provide some power.
Threat of new substitutes: Low as no major substitute exists for veterinary
pharmaceutical products. However, demand for alternative therapies presents a
medium threat.
Competitive rivalry: High as the market has many global and regional players.
Intense competition on pricing and new product development keeps rivalry high.
Key Takeaways
The global Veterinary Medicine Market is expected to witness high growth over the
forecast period of 2024 to 2031. The global veterinary medicine market is
estimated to be valued at US$ 39.27 million in 2024 and is expected to exhibit
a CAGR of 5.0% over the forecast period 2024 to 2031.
Regional analysis: North America dominated the market in 2024 due to high pet
adoption rates and growing pet healthcare expenditure in the region. Asia
Pacific is expected to be the fastest growing market due to rising awareness,
increasing livestock population and growing meat consumption.
Key players: Key players operating in the Veterinary Medicine market are BASF
SE, BP Plc., China Petroleum & Chemical Corporation, ExxonMobil
Corporation, IRPC Plc., LyondellBasell Industries Holdings B.V., and SABIC. Key
players are focused on expanding their product portfolio through acquisitions
and strategic collaborations with veterinary hospitals and clinics.
Get more insights on this topic: https://www.insightprobing.com/veterinary-medicine-market-growth-demand-and-overview/
Comments
Post a Comment